2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Multiple Myeloma
2
Depression
2
Breast Neoplasms
2
Anxiety Disorders
2
Uveal Melanoma
1
Small Cell Lung Carcinoma
1
Prolactin-Producing Pituitary Tumor
1
Pituitary ACTH Hypersecretion
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Solid Tumor Cancers
1
Lung Neoplasms
1
Glioma
1
Glioblastoma
1
Cushing Syndrome
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Caregivers
1
Interventions
Carboplatin
784
Pemetrexed
607
Cisplatin
545
Paclitaxel
491
pembrolizumab
464
Docetaxel
440
Gemcitabine
328
Erlotinib Hydrochloride
307
Radiotherapy
258
Nivolumab
244
Bevacizumab
233
osimertinib
178
Drug Therapy
164
durvalumab
157
atezolizumab
135
Gefitinib
134
Radiosurgery
133
Vinorelbine
111
Cetuximab
97
130-nm albumin-bound paclitaxel
94
Ipilimumab
86
Magnetic Resonance Spectroscopy
84
Taxes
79
Surgical Procedures, Operative
74
Afatinib
68
Albumin-Bound Paclitaxel
66
Specimen Handling
61
Etoposide
61
Cyclophosphamide
60
tislelizumab
59
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
4-amino-4'-hydroxylaminodiphenylsulfone
×
Clear all
NCT07243132
2026-04-27
LUNGEVITY
Groupe Francais De Pneumo-Cancerologie
Recruiting
1,000 enrolled